NCT05336695View on ClinicalTrials.gov

Assess Fibrin in Brains With AD/ADRD

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 29, 2022

Primary Completion Date

September 28, 2025

Study Completion Date

September 28, 2026

Conditions
Alzheimer DiseaseDementia of Alzheimer Type
Interventions
DIAGNOSTIC_TEST

PET/MR Imaging

PET/MRI Scan with \[64Cu\]FBP8 as directed by protocol

DRUG

64Cu-FBP8

Will be administered by intravenous injection by bolus by a qualified nuclear medicine technician at the Martinos Center

Trial Locations (1)

02115

RECRUITING

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Massachusetts General Hospital

OTHER